<?xml version="1.0" encoding="UTF-8"?>
<ref id="r100">
 <label>100</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Busso</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Karababa</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Nobile</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Rolaz</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Van Gool</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Galli</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Leo</surname>
   <given-names>O</given-names>
  </string-name>, 
  <string-name>
   <surname>So</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>De Smedt</surname>
   <given-names>T</given-names>
  </string-name>. 
  <article-title>Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD.</article-title>
  <source>PLoS One</source>. 
  <year>2008</year>; 
  <volume>3</volume>:
  <fpage>e2267</fpage>. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0002267</pub-id>
  <?supplied-pmid 18493620?>
  <pub-id pub-id-type="pmid">18493620</pub-id>
 </mixed-citation>
</ref>
